| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0005525> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0013125> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0013154> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0015198> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0021054> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0063717> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0085415> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0085421> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0087113> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0162717> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0206012> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0282439> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0282460> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0600378> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0919747> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C0948245> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C1527392> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C1609165> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C1720825> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C2740854> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C2830231> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C2985546> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C3272237> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C3850123> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C4704925> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C5226663> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C5227770> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C5227771> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C5227772> <https://research.tib.eu/covid-19/entity/33031955_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy.\', \'AORN Ospedali dei Colli -Monaldi -Cotugno- CTO, Napoli, Italy.\', \'Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Azienda USL-IRCCS di Reggio Emilia, Italy; Università degli Studi di Modena e Reggio Emilia, Italy.\', \'Regione Emilia Romagna e CTS AIFA, Italy.\', \'Università degli Studi di Modena e Reggio Emilia, Italy.\', \'Istituto Superiore di Sanità e CTS AIFA, Italy.\', \'Università degli Studi della Campania Luigi Vanvitelli, Italy.\', \'Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy. Electronic address: f.perrone@istitutotumori.na.it.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Arenare_Laura> <https://research.tib.eu/covid-19/entity/Ascierto_Paolo> <https://research.tib.eu/covid-19/entity/Atripaldi_Luigi> <https://research.tib.eu/covid-19/entity/Botti_Gerardo> <https://research.tib.eu/covid-19/entity/Cascella_Marco> <https://research.tib.eu/covid-19/entity/Chiodini_Paolo> <https://research.tib.eu/covid-19/entity/Costantini_Massimo> <https://research.tib.eu/covid-19/entity/Dolci_Giovanni> <https://research.tib.eu/covid-19/entity/Facciolongo_Nicola> <https://research.tib.eu/covid-19/entity/Fraganza_Fiorentino> <https://research.tib.eu/covid-19/entity/Gallo_Ciro> <https://research.tib.eu/covid-19/entity/Marata_AnnaMaria> <https://research.tib.eu/covid-19/entity/Massari_Marco> <https://research.tib.eu/covid-19/entity/Montesarchio_Vincenzo> <https://research.tib.eu/covid-19/entity/Mussini_Cristina> <https://research.tib.eu/covid-19/entity/Negri_Emanuele_Alberto> <https://research.tib.eu/covid-19/entity/Parrella_Roberto> <https://research.tib.eu/covid-19/entity/Perrone_Francesco> <https://research.tib.eu/covid-19/entity/Piccirillo_Maria_Carmela> <https://research.tib.eu/covid-19/entity/Popoli_Patrizia> <https://research.tib.eu/covid-19/entity/Salvarani_Carlo>
?:doi	S1551-7144(20)30243-310.1016/j.cct.2020.106165
?:doi	<https://research.tib.eu/covid-19/entity/S1551-7144%2820%2930243-310.1016/j.cct.2020.106165>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Clinical_Trial_Protocol> <https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Contemporary clinical trials
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33031955>
?:pmid	<https://research.tib.eu/covid-19/entity/33031955>
?:pmid	33031955
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.536
?:rankingScore_hIndex	48
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0021760_AFFECTS_C2905612> <https://research.tib.eu/covid-19/entity/C0030054_COEXISTS_WITH_C3536832> <https://research.tib.eu/covid-19/entity/C0032285_PROCESS_OF_C0870668> <https://research.tib.eu/covid-19/entity/C0035222_COEXISTS_WITH_C0032285> <https://research.tib.eu/covid-19/entity/C0748358_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C2985546_COEXISTS_WITH_C3536832> <https://research.tib.eu/covid-19/entity/C3846446_PROCESS_OF_C0599755>
?:title	TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy.\', \'AORN Ospedali dei Colli -Monaldi -Cotugno- CTO, Napoli, Italy.\', \'Azienda USL-IRCCS di Reggio Emilia, Italy.\', \'Azienda USL-IRCCS di Reggio Emilia, Italy; Università degli Studi di Modena e Reggio Emilia, Italy.\', \'Regione Emilia Romagna e CTS AIFA, Italy.\', \'Università degli Studi di Modena e Reggio Emilia, Italy.\', \'Istituto Superiore di Sanità e CTS AIFA, Italy.\', \'Università degli Studi della Campania Luigi Vanvitelli, Italy.\', \'Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy. Electronic address: f.perrone@istitutotumori.na.it.\']

?:citedBy

-1

?:creator

?:doi

S1551-7144(20)30243-310.1016/j.cct.2020.106165

?:doi

<https://research.tib.eu/covid-19/entity/S1551-7144%2820%2930243-310.1016/j.cct.2020.106165>

?:hasPublicationType

?:journal

Contemporary clinical trials

is ?:pmid of

<https://research.tib.eu/covid-19/entity/33031955>

?:pmid

<https://research.tib.eu/covid-19/entity/33031955>

?:pmid

33031955

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/Covid-19>

?:rankingScore_SJR

1.536

?:rankingScore_hIndex

is ?:relation_isRelatedTo_publication of

?:title

TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol.

?:type

?:year

2020

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33031955>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33031955>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

Metadata